Cepheid Expands Distribution in China
Sunnyvale, Calif. - Cepheid announced that it has executed a non-exclusive distribution agreement with Gene Company for distribution of Cepheid's products in the Clinical Research and Life Sciences markets in China and Hong Kong.
"Gene Company represents a significant quality distribution partner for a potentially large market," stated Ira Marks, Cepheid VP Worldwide Sales & Marketing. "This represents an additional step in strengthening our distribution capability in markets outside of the USA, Europe and Japan."
The agreement is a non-exclusive, 3-year term for distribution of Cepheid's SmartCycler Systems, accessories and OmniMix HS reagents across China and Hong Kong. Gene Company has been in business since 1992 with approximately US$35 million in sales in 2003. The company has 18 offices across China, including its Hong Kong headquarters, and employs over 250 people. Gene Company is a part of Gene Group Holdings, which consists of the following subsidiaries: Genetech -- an R&D laboratory facility for developing its own line of reagent products; ebiotrade -- currently the largest biotech portal in China http://www.ebiotrade.com; and Ecotech -- an instrument and reagent sales organization specifically targeting environmental and agricultural markets.
Most read news
Other news from the department business & finance
![Newsletter](https://img.chemie.de/assets/awportal/images/newsletter.png)
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.